Journals / Üroonkoloji Bülteni / 2017 / Cilt: 16 - Sayı: 1

The Relationship between Bladder Cancer and Epigenetic Alterations

Epigenetik Değişiklikler ve Mesane Kanseri Arasındaki İlişki

Pages
17–21
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

With the understanding of epigenetic changes better patient outcomes will be achieved in the future

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Bladder cancer is one of the most common cancers of urinary system and approximately 70% of the cases are low grade and non-muscle invasive.
📊
Key Findings & Data:Epigenetic changes include 3 main titles; DNA methylation, micro RNA regulation and histone modification.
💡
Conclusion & Impact:With the understanding of epigenetic changes better patient outcomes will be achieved in the future
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Bladder cancer is one of the most common cancers of urinary system and approximately 70% of the cases are low grade and non-muscle invasive. Because of the histological indicator inadequacy of heterogeneous tumors like bladder cancer, researchers tend to look into genetic and molecular markers. Furthermore, role of epigenetic changes in cancer biology to be more distinctive than other cellular changes was shown. Epigenetic changes include 3 main titles; DNA methylation, micro RNA regulation and histone modification. In the literature, many epigenetic changes were found to be associated with early detection of the disease, progression, patient prognosis, tumor recurrence, early relapse, higher pathologic stage, disease-specific survival. With the understanding of epigenetic changes better patient outcomes will be achieved in the future

Özet

Mesane tümörleri üriner sistemin en sık görülen kanserlerinden olup olguların yaklaşık %70'i düşük dereceli ve kasa invaze olmayan tümörlerdir. Mesane kanseri gibi heterojen bir yapıya sahip tümörlerde histolojik göstergelerdeki yetersizlik nedeniyle, araştırmacılar genetik ve moleküler belirteçlere yönelmişlerdir. Ayrıca kanser biyolojisinde epigenetik değişikliklerin rolünün diğer hücresel değişikliklere göre daha fazla rol oynadığı da gösterilmiştir. Epigenetik değişiklikler DNA metilasyonu, mikro RNA regülasyonu ve histon modifikasyonu olmak üzere üç ana başlık altında incelenir. Literatürde birçok epigenetik değişikliğin hastalığın erken tanısı, progresyonu ve hasta prognozu, tümör rekürrensi, erken relaps, ileri patolojik evre, hastalığa spesifik sağkalım ile ilişkili olduğu gösterilmiştir. Epigenetik değişikliklerin anlaşılması ile gelecekte hastalarla ilgili daha iyi sonuçlar elde edilecektir.

🔖

Cite This Article

ÖZEN, A., ÜLGEN, A., CAN, Y. S. C. (2017). The Relationship between Bladder Cancer and Epigenetic Alterations. Üroonkoloji Bülteni, Cilt: 16 - Sayı: 1, 17–21. https://ajindex.com/articles/334883

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (19)

  1. MacVicar AD. Bladder cancer staging. BJU Int 2000;86(Suppl 1):111-122
  2. Messing EM, Young TB, Hunt VB, et al. Comparison of bladder cancer outcome in men undergoing hematuria home screning versus those with standard clinical presentations. Urology 1995;45:387-396
  3. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100:57-70
  4. Baffa R, Letko J, McClung C, et al. Molecular genetics of bladder cancer: targets for diagnosis and therapy. J Exp Clin Cancer Res 2006;25:145-160
  5. Lopez-Beltran A, Sauter G, Gasser T, et al. Infiltrating urothelial carcinoma. In: Eble NJ, Sauter G, Epstein JI, editors. World Health Organization Classification of Tumours, Tumours of the Urinary System and Male Genital Organs. France: Lyon; 2004. p. 90-109
  6. Esteller M. Epigenetics in cancer. N Engl J Med 2008;358:1148-1159
  7. Feinberg AP, Tycko B. The history of cancer epigenetics. Nat Rev Cancer 2004;4:143-153
  8. Jerenimo C, Henrique R. Epigenetic biomarkers in urological tumors: A systematic review. Cancer Letters 2014;342:264-274
  9. Hoffman AM, Cairns P. Epigenetics of kidney cancer and bladder cancer. Epigenomics 2011;3:19-34
  10. Harb-De La Rosa A, Acker M, Kumar Ra, Manoharan M. Epigenetics applicationin the diagnosis and treatment of bladder cancer. Can J Urol 2015;22:7947-7951
  11. Goldberg AD, Allis CD, Bernstein E. Epigenetics: a landscape takes shape. Cell 2007;128:635-638
  12. Lopez-Serra L, Esteller M. Proteins that bind methylated DNA and human cancer: reading the wrong words. British J Cancer 2008;98:1881-1885
  13. Wang X, Zhang L, Ding N, et al. Identification and characterization of DNAzymes targeting DNA methyltransferaze I for suppressing bladder cancer proliferation. Biochem Biophys Res Commun 2015;461:329-333
  14. Vaissière T, Sawan C, Herceg Z. Epigenetic interplay between histone modifications and DNA methylation in gene silencing. Mut Res 2008;659:40-48
  15. Clark SJ, Melki J. DNA methylation and gene silencing in cancer: which is the guilty party? Oncogene. 2002;21:5380-5387
  16. ScaranoMI, Strazzullo M, Matarazzo MR, D’Esposito M. DNA methylation 40 years later: its role in human health and disease. J Cell Physiol 2005;204:21-35
  17. Attwood JT, Yung RL, Richardson BC. DNA methylation and the regulation of gene transcription. Cell Mol Life Sci 2002;59:241-257
  18. Tost J. DNA Methylation: Methods and Protocols 2nd ed. New York: Humana Press; 2009
  19. Sharma S, Kelly TK, Jones PA. Epigenetics in cancer. Carcinogenesis 2010;31:27-36.